Medical notice: Educational content only. CanduCardio is intended for healthcare professionals and CanduTV for the general public. It does not replace clinical judgment or professional consultation.
Therapy group: Anticoagulation · Therapy: Apixaban vs. rivaroxaban in acute venous thromboembolism
In acute venous thromboembolism, apixaban caused significantly less clinically relevant bleeding than rivaroxaban over three months of treatment.
Published in N Engl J Med (2026)
Card generated automatically with AI from the abstract of the original publication and the trial registry; every figure was checked against those sources. It may contain errors: verify the data at the source before using it for clinical decisions.
Generated on October 14, 2026
Educational content only. CanduCardio is intended for healthcare professionals and CanduTV for the general public. It does not replace clinical judgment or professional consultation.